Iatrogenic botulism cases after gastric and axillary application of botulinum toxin and review of literature

Authors

  • Fatma Eser Ankara Yildirim Beyazit University, Ankara City Hospital, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey https://orcid.org/0000-0002-0282-6346
  • İmran Hasanoğlu Ankara Yildirim Beyazit University, Ankara City Hospital, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey https://orcid.org/0000-0001-6692-3893
  • Bircan Kayaaslan Ankara Yildirim Beyazit University, Ankara City Hospital, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey
  • Ayşe Kaya Kalem Ankara Yildirim Beyazit University, Ankara City Hospital, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey
  • Şule Bilen University of Health Sciences, Ankara City Hospital, Department of Neurology, Ankara, Turkey
  • Gürdal Orhan University of Health Sciences, Ankara City Hospital, Department of Neurology, Ankara, Turkey
  • Rahmet Güner Ankara Yildirim Beyazit University, Ankara City Hospital, Department of Infectious Disease and Clinical Microbiology, Ankara, Turkey

DOI:

https://doi.org/10.3855/jidc.18868

Keywords:

botulism, iatrogenic, botulinum toxin, antitoxin

Abstract

Introduction: Iatrogenic botulism is a rare, serious disease that progresses with descending paralysis and develops after cosmetic or therapeutic botulinum toxin-A (BoNT-A) application.

Case presentations: In this case series; six cases of iatrogenic botulism followed up in our center are presented. Four of these developed after gastric BoNT-A and two after axillary BoNT-A application.

Results: The most important cause for the disease was the use of unlicensed products and high-dose toxin applications. The first symptoms were blurred vision, double vision, difficulty in swallowing, and hoarseness. Symptoms appeared within 4-10 days after the application of BoNT-A. Symptoms progressed in the course of descending paralysis in the following days with fatigue, weakness in extremities and respiratory distress. Diagnosis was based on patient history and clinical findings. The main principles of foodborne botulism therapy were applied in the treatment of iatrogenic botulism. If clinical worsening continued, regardless of the time elapsed after BoNT-A application, the use of botulinum antitoxin made a significant contribution to clinical improvement and was recommended.

Conclusions: Routine and new indications for BoNT-A usage are increasing and, as a result, cases of iatrogenic botulism will be encountered more frequently. Physicians should be alert for iatrogenic botulism in the follow-up after BoNT-A applications and in the differential diagnosis of neurological diseases that are presented with similar findings.

Downloads

Published

2024-03-31

How to Cite

1.
Eser F, Hasanoğlu İmran, Kayaaslan B, Kaya Kalem A, Bilen Şule, Orhan G, Güner R (2024) Iatrogenic botulism cases after gastric and axillary application of botulinum toxin and review of literature. J Infect Dev Ctries 18:480–487. doi: 10.3855/jidc.18868

Issue

Section

Case Reports